BRITISH PHARMACOLOGICAL SOCIETY
Financial health, per its FY2024 accounts
The accounts state that total funds increased by £641,867 to £6,349,143, driven by a £230,015 net gain on investments and a surplus in charitable activities. The charity holds unrestricted reserves of £5,813,112, which the trustees consider to be 134% of their stated policy requirement of £3,000,000. The trustees confirm adequate resources for the foreseeable future, with no material uncertainties identified by the auditors.
What the accounts disclose
“In the band £120,001 - £130,000” — page 31
“The Trustees consider that the Society’s reliance on publishing income is the predominant determinant of the level of reserves required and have calculated that a level of £3,000,000 would allow the Society to fulfil is commitments to its members both in terms of operations and activities over a period of one year if the Society’s publications income failed or were severely reduced as well as covering other potential adverse scenarios.”
“During the course of the year the Society transacted with BPS Assessment Limited and BPS Trading Services, its wholly-owned subsidiary undertaking. The amounts owing to and from the subsidiary are included in notes 17 and 18.” — page 39
“The Group (the Society and its trading subsidiaries, BPS Assessment Limited and BPS Trading Services Limited).”
Corporate structure
- Registered company of the charity Companies House 02877400
- Trading subsidiary: BPS ASSESSMENT LIMITED Companies House 09973409
- Trading subsidiary: BPS TRADING SERVICES LIMITED Companies House 09973456
Funders the charity credits
- Eli Lilly and Company
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- Dr Heather Giles
- Dr Niall Patrick Hyland
- Dr Yousif Shamsaldeen
- Edward Briffa
- Professor Cherry Lindsey Wainwright
- Professor Farhan Ahmad Khan
- Professor James Michael Ritter
- Professor Michael Spedding
- Professor Simon Robert Jenkinson Maxwell
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £4.7m | £4.3m |
| 31/12/2023 | £5.3m | £5.6m |
| 31/12/2022 | £4.3m | £4.6m |
| 31/12/2021 | £4.5m | £4.2m |
| 31/12/2020 | £4.4m | £4.2m |
Common questions
Is BRITISH PHARMACOLOGICAL SOCIETY financially healthy?
The accounts state that total funds increased by £641,867 to £6,349,143, driven by a £230,015 net gain on investments and a surplus in charitable activities. The charity holds unrestricted reserves of £5,813,112, which the trustees consider to be 134% of their stated policy requirement of £3,000,000. The trustees confirm adequate resources for the foreseeable future, with no material uncertainties identified by the auditors. Its FY2024 accounts were audited by Moore Kingston Smith LLP.
What does the highest-paid employee of BRITISH PHARMACOLOGICAL SOCIETY earn?
Per its FY2024 accounts, the highest-paid employee was in the £120,001 - £130,000 band.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| NPT Transatlantic Limited | 1 | £30.9m |
| THE COMPANY OF BIOLOGISTS | 1 | £140k |
| THE MURIEL AND GERSHON COREN CHARITABLE FOUNDATION | 1 | £80k |
| B K CHARITABLE TRUST | 1 | £72k |
| THE JMCMRJ SORRELL FOUNDATION | 1 | £50k |
| BETTENHURST CHARITY LIMITED | 1 | £16k |
| THE VIVIENNE AND SAMUEL COHEN CHARITABLE TRUST | 1 | £14k |
| THE J AND H ORLANDER TRUST | 1 | £2k |